Yahoo Finance

Cytokinetics Announces Data From Phase 1 Study of CK-4021586

SOUTH SAN FRANCISCO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that data from the Phase 1 study of CK-4021586 (CK-586) were presented in a ...
Yahoo Finance

All Three Projects Powered by QuEra Computing Contributions Move to Phase Two of Wellcome Leap's Quantum for Bio Challenge, Focused on Healthcare and Biology Applications

BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- QuEra Computing, the leader in neutral-atom quantum computing, today announced that all three research projects in which QuEra is involved have advanced to ...
Benzinga.com

Cytokinetics Sets Stage For Mid-Stage Study For Heart Failure Drug After Encouraging Data From Phase 1 Study

The half-life of CK-586 was observed to be in the range of 14 to 17 hours. The data support the advancement of CK-586 to a Phase 2 trial for heart failure with preserved ejection fraction, expected to ...
Nasdaq

Cytokinetics: Phase 1 Study Of CK-4021586 Meets Primary And Secondary Objectives

(RTTNews) - Cytokinetics (CYTK) presented data from the Phase 1 study of CK-4021586, or CK-586. The study met its primary and secondary objectives to assess the safety, tolerability and ...
Nasdaq

Quantum Computing, Inc. Awarded Contract by NASA to Support Phase Unwrapping Using Dirac-3 Photonic Optimization Solver

HOBOKEN, N.J., Dec. 17, 2024 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today announced ...